Validation in the general population of a C-peptide estimate equation to measure beta cell function in recent-onset type 1 diabetes
- PMID: 32940799
- DOI: 10.1007/s00592-020-01604-7
Validation in the general population of a C-peptide estimate equation to measure beta cell function in recent-onset type 1 diabetes
Erratum in
-
Correction to: Validation in the general population of a C-peptide estimate equation to measure beta cell function in recent-onset type 1 diabetes.Acta Diabetol. 2021 Jan;58(1):119. doi: 10.1007/s00592-020-01616-3. Acta Diabetol. 2021. PMID: 33067722 No abstract available.
References
-
- Wentworth JM, Bediaga NG, Giles LC, Ehlers M, Gitelman SE, Geyer S et al (2019) Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables. Diabetologia 62(1):33–40 - DOI
-
- Wentworth JM, Bediaga NG, Gitelman SE, Evans-Molina C, Gottlieb PA, Colman PG et al (2020) Clinical trial data validate the C-peptide estimate model in type 1 diabetes. Diabetologia 63(4):885–886 - DOI
-
- Culina S, Lalanne AI, Afonso G, Cerosaletti K, Pinto S, Sebastiani G, et al. Islet-reactive CD8(+) T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors. Sci Immunol. 2018;3(20).
-
- Mortensen HB, Hougaard P, Swift P, Hansen L, Holl RW, Hoey H et al (2009) New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 32(8):1384–1390 - DOI
-
- Greenbaum CJ, Beam CA, Boulware D, Gitelman SE, Gottlieb PA, Herold KC et al (2012) Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes 61(8):2066–2073 - DOI
LinkOut - more resources
Full Text Sources